The Conquer Cancer–Jazz Glioma Quality Improvement Grant 2026 supports projects designed to improve equitable, guideline-concordant molecular testing and care for pediatric and adult patients with glioma in the United States.
The program focuses on practical, evidence-based quality improvement strategies that can identify gaps in current care and implement measurable solutions. Individual projects may receive up to $125,000 over two years.
Eligibility Criteria
- Eligible applicants include U.S. healthcare delivery systems.
- Academic and community oncology delivery networks in the United States may apply.
- Only organizations and institutions may receive funding.
- The principal investigator must be an employee or contractor of the applying organization.
- Multidisciplinary teams delivering care to patients with glioma are encouraged.
- Projects must focus on improving guideline-concordant molecular testing and glioma care.
Funding Details
- Funding: Up to $125,000 per project
- Duration: 2 years
- Total funding available: $1 million
Deadline
- Applications opened: September 1, 2026
- Application deadline: October 16, 2026, at 11:59 PM ET
- Anticipated proposal notification: End of November 2026
Further Information
- Applications must be submitted through the EveryGrant application portal.
- Official Conquer Cancer–Jazz Glioma Quality Improvement Grant